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Abstract
Background
The angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism (rs4340) (ACE DIP) accounts for half of the variability in plasma ACE
concentrations. ACE has been widely studied for its influence on sports performance; however, research on its influence in physical activity is limited and
inconsistent. We examined the influence of the ACE DIP on physical activity
among 461 European Americans.
Methods
Subjects completed the Paffenbarger Physical Activity Questionnaire for weekly
walking distance. Multivariate analysis of covariance (MANCOVA) tested logtransformed differences in weekly walking distance among ACE DIP genotypes
(II, ID, DD) with gender as a fixed factor, and age and body mass index (BMI)
as covariates. Because we found a significant ACE DIPxBMI interaction
(P = 0.03), we categorized the sample by normal weight (NW: BMI<25.0 kg/
m2) and overweight (OW: BMI ≥25.0 kg/m2) and repeated the MANCOVA
with multiple comparison adjustments.
Results
NW adults with ACE II walked 15.8  11.1 km/week, ID 13.2  10.6 km/
week, and DD 17.9  13.0 km/week, with ID walking less than II (P = 0.03)
and DD (P = 0.01). OW adults with ACE II walked 16.7  12.6 km/week, ID
13.8  11.6 km/week, and DD 9.7  9.0 km/week, with DD walking less than
II (P = 0.02). Weekly walking distance was 8.2  2.4 km/week less among OW
adults with ACE DD than NW (P = 0.02).

ª 2017 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.

M. Bruneau Jr et al.

Angiotensin-Converting Enzyme, Exercise, Genes

Conclusion
BMI interacted with ACE DD such that OW walked ~8.2 km/week less than
NW, potentially equating to a body weight differential of ~3.5 kg annually.

Introduction
The angiotensin-converting enzyme (ACE) is a biological
catalyst for the conversion of angiotensin I to angiotensin
II, a potent vasoconstrictor in the renin-angiotensin aldosterone system (RAAS). Angiotensin II stimulates the release
of aldosterone and antidiuretic hormone, actions which
increase renal sodium and water reabsorption, stimulate
thirst, and modulate sympathetic vascular tone. The ACE
insertion (I) deletion (D) polymorphism (ACE DIP; OMIM
+106180; GenBank KJ140509.1) (rs4340) is a 287-base pair
sequence within intron 16 of chromosome 17q23 that
accounts for half of the variability in plasma ACE concentrations (Cambien et al. 1988; Wong et al. 2012). Those
homozygous for the D allele of the ACE DIP exhibit higher
serum ACE and angiotensin II levels and less bradykinin
levels, a vasodilator, than those homozygous for the I allele
of the ACE DIP (Wong et al. 2012).
Due to its influence on cardiovascular and renal function, the ACE DIP has been examined extensively as a
polymorphism that influences sports performance as well
as the response of health-related phenotypes to acute (i.e.,
short-term) and chronic (i.e., long-term or training) exercise (Hagberg et al. 1998; Woods et al. 2000a,b; Zhang
et al. 2003; Jones et al. 2002; Jones and Woods 2003; Williams et al. 2000; Rankinen et al. 2000; Pescatello et al.
2006; Kostis et al. 2002). Those homozygous for the I
allele of the ACE DIP exhibit higher maximal and submaximal oxygen consumption (Hagberg et al. 1998;
Woods et al. 2000a,b), a greater propensity of type 1
muscle fibers (Zhang et al. 2003), and enhanced substrate
utilization for long-term and sustained aerobic activities
(Jones et al. 2002; Jones and Woods 2003; Williams et al.
2000). In contrast, those homozygous for the D allele of
the ACE DIP exhibit a higher propensity of type 2 muscle
fibers and perform better at strength and anaerobic sport
activities (Zhang et al. 2003).
The literature regarding the association of the ACE DIP
with habitual physical activity is much more limited (Wong
et al. 2012; Hagberg et al. 1998; De Moor et al. 2009;
Fuentes et al. 2002; Winnicki et al. 2004). Those homozygous for the I allele of the ACE DIP have been reported to
engage in higher levels of habitual physical activity than
those homozygous for the D allele of the ACE DIP (Wong
et al. 2012; Winnicki et al. 2004), but this finding has been
inconsistent across studies (Hagberg et al. 1998). Reasons
for this discrepant literature are not clear, but may be due
to a limited number of investigations that had small

heterogeneous samples that may have been underpowered,
and/or lacked statistical control for potential confounders
that would influence possible associations with the ACE
DIP and habitual physical activity such as age and body
mass index (BMI) (Wong et al. 2012; Hagberg et al. 1998;
De Moor et al. 2009; Fuentes et al. 2002; Winnicki et al.
2004). The purpose of our study was to examine associations of the ACE DIP with habitual physical activity among
a large sample of 461 European American adults from the
Functional Single Nucleotide Polymorphisms Associated with
the Human Muscle Size and Strength (FaMuSS, NIH R01
NS40606-02) study. We hypothesized that those homozygous for the I allele of the ACE DIP would report higher
levels of habitual physical activity compared to those
homozygous for the D allele.

Methods
Ethical compliance
The FaMuSS study was a multi-center trial conducted by
the Exercise and Genetics Collaborative Research Group
consisting of researchers from the University of Central
Florida, University of Massachusetts, West Virginia
University, Dublin City University, University of Connecticut, Central Michigan University, Florida Atlantic
University, Yale University, Hartford Hospital, and the
Children’s National Medical Center. The institutional
review boards from all 10 institutions approved the study
protocol. The primary aim of FaMuSS was to identify
genetic factors that dictated the response of health-related
fitness phenotypes to resistance exercise training (RT).
Prior to RT, investigators obtained blood samples for
determination of cardiometabolic profiles and DNA
extraction, and assessed habitual physical activity with the
Paffenbarger Physical Activity Questionnaire. The experimental design of FaMuSS has been described elsewhere,
so only the methods related to this substudy are described
(Pescatello et al. 2013).

Subjects
All subjects provided written informed consent. Subjects
were excluded if they: (1) had performed RT within the
past year; (2) had a chronic health condition that would
preclude their ability to perform RT; (3) had metal
implants in the arms, eyes, head, brain, neck, and/or heart
that would be contraindicated to magnetic resonance
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imaging (MRI); (4) were prescribed and/or taking
medications (i.e., corticosteroids, anabolic steroids, antihypertensive or antilipidemic medications, diuretics,
Depo-Provera contraceptive injection, Clenbuterol, Rhinocort nasal inhaler, lithium nonsteroidal anti-inflammatory medications) known to effect skeletal muscle
function; (5) consumed an average of ≥2 alcoholic drinks
per day; (6) consumed dietary supplements to enhance
muscle strength and size or weight; or (7) gained or lost
>2.2 kg of body weight within 3 months prior to enrolling in the study. In all, 461 European American adults
(≥18 years) were genotyped for the ACE DIP (rs4340)
and comprised the sample for this substudy.

Physical activity
Upon enrollment into FaMuSS, subjects were measured
for body weight (kg) and height (cm) to determine BMI
(kg/m2). Subjects then completed the Paffenbarger Physical Activity Questionnaire to assess weekly habitual physical activity over the past year, including informal
activities of daily living (e.g., city blocks walked and stairs
climbed), leisure time activities, and formal exercise (Paffenbarger et al. 1978). Physical activity scores in kcal/week
were calculated based on the sum of calories expended
across durations and intensities of the different activities
reported. The Paffenbarger Physical Activity Questionnaire has excellent reliability and predictive validity and is
sensitive to changes to interventions (Pereira et al. 1997;
Harris et al. 1994; Jeffery et al. 1998). The physical activity phenotype examined in this substudy was derived
from the following question: “How many city blocks or
their equivalent did you walk on an average day during
the past year?”. The self-reported weekly walking distance
in kilometers (km) per week was totaled and used for
comparison among the ACE DIP genotypes.

Genotyping
Fasting blood samples (21 mL) were taken from each subject in standard EDTA vacutainer tubes (Becton Dickson
and Company, Franklin Lakes, NJ, USA). Serum blood
samples were centrifuged at 4°C and were spun at 1100 9
g per min for 10 min. Hemolysized samples were redrawn
as a quality control measure. The samples were then
refrigerated and stored at 80°C until being transported
to the Children’s National Medical Research Center in
Washington, DC. DNA was isolated from peripheral blood
lymphocytes with a Gentra Puregene DNA extraction kit
(Qiagen, Valencia, CA, USA) and ACE DIP (rs4340) genotypes (II, ID, DD) were determined with TaqMan allele
discrimination assays employing a 5’ nuclease activity of
Taq polymerase to detect a fluorescent reporter signal
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generated during polymerase chain reactions. Endpoint
fluorescent readings for ACE DIP genotypes were then
performed with a standard ABI 7900HT Sequence Detection System (SDS V 2.3 software; Applied Biosystems, Foster City, CA, USA). All genotyping was performed in
duplicate as a quality control measure and any disagreements in genotype readings were repeated.

Statistical analysis
Descriptive statistics were calculated as means (X)  standard deviations (SD) for all variables, unless otherwise
noted. Chi-square analysis was used to confirm that the
ACE DIP (rs4340) was in Hardy–Weinberg equilibrium
(HWE) with genotype frequencies of 25.8% (II), 46.2%
(ID), and 28.0% (DD). Multivariate analysis of covariance
(MANCOVA) was used to test log-transformed differences
in weekly walking distance among ACE DIP genotypes (II,
ID, DD) with gender as a fixed factor and age and BMI as
covariates. Because a significant ACE DIPxBMI interaction
was found (P = 0.03), we categorized the sample into normal weight (NW: BMI ≤24.9 kg/m2) and overweight (OW:
BMI >24.9 kg/m2) groups. We then repeated the MANCOVA with gender and BMI groups as fixed factors and
age as a covariate. Post hoc univariate ANCOVAs and subsequent pairwise comparisons were assessed with simple
effects tests and multiple comparison adjustments with corrected alpha levels set at P < 0.02. All analyses were performed using the Statistical Package for the Social Sciences
(SPSS, Armonk, NY, USA) 21.0.

Results
Subject characteristics
The sample included 461 European Americans who on
average were young, normal weight (n = 307, BMI = 21.7
 1.8 kg/m2) or overweight (n = 154, BMI = 29.6
 4.4 kg/m2) men (n = 203, 44%) and women (n = 258,
56%) (Table 1). Subject physical characteristics did not differ by ACE DIP (rs4340) genotype (P > 0.05), but did differ
by gender for height, weight, and BMI (P < 0.05). When
the sample was divided by BMI as NW or OW groups,
OW subjects were older than NW subjects (P < 0.05)
(Table 2).

ACE DIP genotypes and weekly walking
distance by BMI group
For NW, subjects with ACE II walked 15.8  11.1 km/
week, ID 13.2  10.6 km/week, and DD 17.9  13.0 km/
week, with ID walking 2.6  1.4 km/week less than II
(P = 0.03) and 4.7  1.6 km/week less than DD
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Table 1. Mean (SD) physical characteristics of the total sample and by ACE DIP (rs4340) genotype.

Variable

Total sample (n = 461)

Age (year)
Weight (kg)
Height (cm)
BMI (kg/m2)

24.1
70.5
169.7
24.3






Genotypes
II (n = 119)

15.7
16.5
19.2
14.8

23.8
70.5
170.1
24.3






15.3
14.8
18.4
14.4

ID (n = 213)
24.2
71.0
169.7
24.6






15.9
17.0
19.6
15.0

DD (n = 129)
24.2
69.7
169.5
24.1






15.8
17.3
19.2
14.7

There were no significant baseline differences in the physical characteristics of subjects among ACE DIP genotypes (P > 0.05). ACE, angiotensinconverting enzyme; I, insertion allele; D, deletion allele; BMI, body mass index.

Table 2. Mean (SD) physical characteristics by BMI group.
Variable

NW (n = 307)

Age (year)
Weight (kg)
Height (cm)
BMI (kg/m2)

23.2
62.3
169.1
21.7






6.4
8.4
8.8
1.8

OW (n = 154)
25.8
87.0
171.0
29.6






16.4‡
16.4‡
19.8‡
14.4‡

P < 0.05, NW versus OW. BMI, body mass index; NW, normal
weight; OW, overweight.

‡

(P = 0.01). For OW, subjects with ACE II walked
16.7  12.6 km/week, ID 13.8  11.6 km/week, and DD
9.7  9.0 km/week, with DD walking 7.1  3.7 km/week
less than II (P = 0.02). When the NW and OW groups
were directly compared, weekly walking distance was
8.2  2.4 km/week less among OW than NW with ACE
DD (P = 0.02) (Fig. 1).

ACE DIP genotypes and weekly walking
distance by body weight classification and
gender
NW men with the II genotype reported walking
0.8  2.6 km/week more than NW women with the II

Figure 1. ACE DIP genotypes and weekly walking distance by BMI
group.

genotype (P = 0.02). No other genotype by physical activity phenotype associations were found among ACE DIP
genotypes, gender, or body weight classification
(P ≥ 0.05).

Discussion
The purpose of this FAMuSS substudy was to determine
whether the ACE DIP (rs4340) was associated with weekly
walking distance in a large sample of healthy European
American adults. The primary finding was that the ACE
DD genotype interacted with BMI such that OW adults
walked, on average, 8.2 km/week less than NW adults.
We also found NW adults with ID walked 2.6 km/week
less than II and 4.5 km/week less than DD; whereas, OW
adults with DD walked 7.1 km/week less than II.
Our findings are consistent with those of Wong et al.
who found that subjects with the ACE D allele had lower
levels of physical activity than those with the I allele
among a sample of 110 Chinese adults with normal blood
pressure. More specifically, they found that those with the
ACE DD genotype expended 1232 fewer kilocalories and
had a 6.88 greater likelihood of engaging in either insufficient or low levels of physical activity compared to those
with the II genotype (Wong et al. 2012). Similarly, Winnicki et al. (2004) investigated the association of the ACE
DIP and physical activity status among 355 Caucasians
with untreated hypertension and found 76% of the sample with the ACE DD and 62% with ID genotypes were
sedentary compared to 48% with the II genotype.
The exact mechanisms to explain the differential effects
of the ACE DIP on habitual physical activity levels are
unclear. However, several biologically plausible explanations exist that support our findings. First, Wong and colleagues theorized that a possible explanation for lower
physical activity levels among those with the ACE D allele
could be attributed to higher serum ACE concentrations
that result in a greater rate of conversion of angiotensin I
to angiotensin II, a potent vasoconstrictor that inhibits
the production of bradykinin, a potent vasodilator. Previous in vivo evidence by Stebbins and Longhurst has supported this proposed mechanism as small doses of
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bradykinin injected into the skeletal muscle of cats was
found to initiate a reflexive change in cardiovascular
hemodynamics, similar to that induced by physical activity and exercise (Stebbins and Longhurst 1985). As a result
of these vascular alterations, Wong et al. speculated that
participation in habitual physical activity may be perceived as more difficult and less desirable to perform in
adults with the ACE D allele compared to those with the I
allele due to a reliance on glycolytic energy pathways from
a diminished oxygen availability in the exercising muscles.
In support of their premise are the findings of Thompson
et al. (2006) who examined the influence of the ACE DIP
on adherence to an endurance exercise training intervention among 110 healthy men and women and found
adherence rates that were 2% and 6% lower for the ID
and DD genotypes compared to the II genotype.
Alternatively, those with the ACE DD genotype have
been shown to possess fewer than 20% of their muscle
fiber types as type 1 (Zhang et al. 2003). Type 1 fibers are
better suited for endurance physical activity such as walking than type 2 fibers that are better suited for resistance
physical activity. Although in vivo evidence of type 1
fibers and habitual physical activity has been limited by a
lack of investigation, animal models bred for low aerobic
performance have shown a smaller proportion of type 1
muscle fibers that were more sensitive to fatigue and had
a slower metabolic recovery from electrically stimulated
exercise (Torvinen et al. 2012). In accordance with these
findings, Thompson et al. postulated that endurance exercise may be more preferable for those with the ACE I
allele than those with the D allele due to differences in
muscle fiber type composition, a postulation that is also
consistent with our findings and those of Wong et al. of
lower physical activity levels in those with the ACE DD
than II genotype (Wong et al. 2012; Thompson et al.
2006).
Evidence for the biological plausibility of our major
finding of OW walking 8.2 km/week less than NW is
lacking. We propose that differences in muscle fiber type
and/or serum ACE levels may account for possible interactions between the ACE DIP and the BMI groups that
we observed. Previous research by Tanner et al. comparing the muscle fiber types of 53 women found lesser
propensities of type 1 and greater propensities of type 2
muscle fibers in women with obesity (Tanner et al. 2001).
Differences in serum ACE levels have also been found
between NW and OW with the ACE DD genotype. ACE
is a membrane-based metallopeptidase located in vascular
endothelial cells that functions as a biological catalyst in
the RAAS. Cooper et al. examined the relationship
between the RAAS and obesity in 500 Jamaican adults
and found higher serum ACE levels among adults with
obesity (Cooper et al. 1997). Furthermore, Rigat et al.
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(1990) explored the relationship between the ACE DIP
and serum ACE in 80 non-Hispanic White adults and
found higher serum ACE levels among adults with the
DD genotype compared to either the II or ID genotypes.
Having a greater preponderance of type 2 muscle fiber
types and/or higher serum ACE levels among adults with
OW and the ACE DD genotype could account for our
finding of walking 8.2 km/week less than adults with NW
and ACE DD due to their higher levels of adiposity.
However, since we did not measure ACE nor determine
muscle fiber type, further research is needed to determine
if our supposition is true.
The present substudy is not without limitation. Because
the primary purpose of FaMuSS was to examine the
influence of genetic variation on human muscle size and
strength in response to RT, this substudy was not
designed to examine habitual physical activity as primary
outcome measure. We assessed physical activity with the
Paffenbarger Physical Activity Questionnaire, a well validated and reliable tool used for the assessment of leisure
time physical activity in similar populations to the population used in FaMuSS. However, the self-reported recall
of habitual physical activity from the previous year may
have been limited by inaccuracies in subject reporting
and/or social desirability bias (Paulhus 1991; Chastin
et al. 2014). We also used BMI as a surrogate measure of
body fat to segregate our subsample into NW and OW
groups, which does not account for differences in muscle
mass nor muscle fiber type between groups (Romero-Corral et al. 2008). Finally, our substudy was not mechanistic
in nature, so we can only speculate on the reported
mechanisms that may explain our findings.
Despite these limitations, our substudy has several
important strengths. To date, the literature regarding the
association of the ACE DIP with habitual physical activity
has been limited due to a small number of investigations
that have included small and heterogeneous samples that
were underpowered to detect statistical associations
between the ACE DIP and physical activity. Our substudy
attempted to address these limitations by including a
large sample of 461 healthy European American adults
that was sufficiently powered to detect our observed effect
size of 0.11 with 83% power at an alpha level set to
P < 0.05 (Faul et al. 2007). Our substudy also controlled
for the potential confounding variables of age and BMI
group, which could have influenced the associations
found between the ACE DIP and weekly walking distance.

Conclusion
In summary, we found the ACE DIP (rs4340) was associated with habitual physical activity in a large sample of
European American adults from FaMuSS. OW adults with
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the DD genotype walked an average of 8.2 km/week less
compared to NW adults with this genotype. This finding
is novel and has clinical significance that could potentially
equate to a body weight differential of ~3.5 kg per year.
Future experimental studies are needed to confirm our
findings and investigate possible mechanisms for the ACE
DIPxBMI interaction we observed with more objective
assessments of physical activity.
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